neostigmine has been researched along with Coronary Heart Disease in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
HERMANN, B | 1 |
CSEPPENTO, I | 1 |
IZSAK, T | 1 |
Ferrara, N | 1 |
Bonaduce, D | 1 |
Abete, P | 1 |
Leosco, D | 1 |
Caccese, P | 1 |
Tuccillo, B | 1 |
Longobardi, G | 1 |
Canonico, V | 1 |
Rengo, F | 1 |
2 other studies available for neostigmine and Coronary Heart Disease
Article | Year |
---|---|
Reflex erythema studies in coronary disease.
Topics: Acetylcholine; Coronary Disease; Erythema; Humans; Neostigmine; Nervous System Physiological Phenome | 1958 |
[Role of the increased cholinergic activity in prevention of reperfusion-induced arrhythmia in dog experiments].
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Dogs; Female; Heart Rate; Male; Neostigmine; Parasy | 1987 |